dabigatran has been researched along with Vitreoretinopathy, Proliferative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastiaans, J; Dik, WA; Mulder, VC; Smits-Te Nijenhuis, M; van Hagen, PM; van Holten-Neelen, C; van Meurs, JC | 1 |
1 other study(ies) available for dabigatran and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Dabigatran inhibits intravitreal thrombin activity.
Topics: Antithrombins; Cells, Cultured; Cytokines; Dabigatran; Gene Expression Regulation; Humans; Intercellular Signaling Peptides and Proteins; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thrombin; Vitreoretinopathy, Proliferative; Vitreous Body | 2018 |